Rothschild & CO Asset Management Us Inc. Harmony Biosciences Holdings, Inc. Transaction History
Rothschild & CO Asset Management Us Inc.
- $6.56 Billion
- Q4 2022
A detailed history of Rothschild & CO Asset Management Us Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Rothschild & CO Asset Management Us Inc. holds 165,088 shares of HRMY stock, worth $6.6 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
165,088
Previous 192,255
14.13%
Holding current value
$6.6 Million
Previous $8.52 Million
6.82%
% of portfolio
0.14%
Previous 0.15%
Shares
6 transactions
Others Institutions Holding HRMY
# of Institutions
228Shares Held
45.4MCall Options Held
48.2KPut Options Held
61.5K-
Valor Management LLC Chicago, IL11.2MShares$448 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$233 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.52MShares$141 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$104 Million11.62% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.51MShares$100 Million0.19% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.36B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...